Development
Predictmedix AI Inc.
PMED
CNSX
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 36.35% | -47.45% | 48.58% | -98.70% | -19.04% |
| Total Depreciation and Amortization | -2.63% | 1.33% | 7.14% | -1.41% | 146.71% |
| Total Amortization of Deferred Charges | -1.68% | 1.28% | -0.42% | 0.00% | -49.14% |
| Total Other Non-Cash Items | -100.00% | 76.43% | -77.80% | 259.98% | 2,606.67% |
| Change in Net Operating Assets | 169.27% | -21.79% | -164.29% | 846.88% | -117.11% |
| Cash from Operations | 80.12% | -34.97% | -1,079.44% | 85.76% | -10,538.46% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 96.96% | 801.63% | -72.80% | -16.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -200.00% | 419.64% | 66.27% | -- |
| Cash from Financing | -100.00% | 75.06% | 587.48% | -56.21% | -31.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -194.26% | 528.16% | -49.28% | 84.37% | -167.59% |